FDA NDC Directory · JSON-LD · Markdown

Cevimeline Hydrochloride

NDC 70771-1982 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA220267
Dosage form / routeCAPSULE · ORAL
Active ingredientsCEVIMELINE HYDROCHLORIDE (30 mg/1)
Marketing started20260415
Package count1

External sources

Source: openFDA. Public-domain (CC0).